Published in Blood on April 15, 1997
The Siblings With Ischemic Stroke Study (SWISS) protocol. BMC Med Genet (2002) 1.82
American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med (2001) 1.70
Combined effects of thrombosis pathway gene variants predict cardiovascular events. PLoS Genet (2007) 1.03
Spontaneous loss of early pregnancy and risk of ischaemic heart disease in later life: retrospective cohort study. BMJ (2003) 0.98
Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease. Ther Adv Musculoskelet Dis (2013) 0.94
Genetic thrombophilia in patients with retinal vascular occlusion. Int Ophthalmol (1999) 0.81
Inhibition of APC anticoagulant activity on oxidized phospholipid by anti-{beta}2-glycoprotein I monoclonal antibodies. Blood (2005) 0.79
Use of Factor V Leiden genetic testing in practice and impact on management. Genet Med (2009) 0.79
Protein C deficiency manifesting as an acute myocardial infarction and ischaemic stroke. Heart (2003) 0.78
[Internal medical investigations for non-arteritic retinal artery occlusion]. Ophthalmologe (2010) 0.77
Low HDL cholesterol, smoking and IL-13 R130Q polymorphism are associated with myocardial infarction in Greek Cypriot males. A pilot study. Open Cardiovasc Med J (2008) 0.77
Factor VLeiden and prothrombin G20210A gene polymorphisms in patients with coronary artery disease. Yonsei Med J (2008) 0.77
Thrombophilia, polymorphisms, and vascular disease. Mol Pathol (2000) 0.77
Are myocardial infarction and venous thromboembolism associated? Population-based case-control and cohort studies. Thromb Res (2014) 0.76
Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen β chain genes with human abdominal aortic aneurysm. Exp Ther Med (2012) 0.75
Off-pump coronary artery bypass graft surgery after stent implantation in a patient with combined thrombophilic risk factors. Can J Cardiol (2007) 0.75
Cardiogenic shock without flow-limiting angiographic coronary artery disease: (from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry). Am J Cardiol (2009) 0.75
Multiple simultaneous venous and arterial thromboses in a patient with factor V Leiden disorder: Detection by multislice computed tomography. Interv Med Appl Sci (2015) 0.75
Ischemic stroke in a patient with hetrozygous factor v leiden mutation: an uncommon association. Indian J Hematol Blood Transfus (2014) 0.75
Should patients with atherosclerosis or peripheral vascular disease be stratified for factor V Leiden? Blood (1997) 0.75
Clinical significance of gene-diagnosis for defects in coagulation factors and inhibitors. Wien Klin Wochenschr (2003) 0.75
Prothrombotic genetic risk factors in patients with very early ST-segment elevation myocardial infarction. J Thromb Thrombolysis (2017) 0.75
Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol (2000) 14.59
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol (1995) 10.26
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation (1995) 9.13
Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature (1994) 9.06
Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med (1996) 8.52
Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics (1998) 8.48
Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med (1999) 8.14
The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA (1995) 7.31
Patient-physician racial concordance and the perceived quality and use of health care. Arch Intern Med (1999) 6.38
Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA (1997) 5.91
Validating administrative data in stroke research. Stroke (2002) 5.90
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet (1994) 5.45
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet (2000) 5.42
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
The messenger under attack -- intimidation of researchers by special-interest groups. N Engl J Med (1997) 5.14
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation (1993) 4.75
A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care (1988) 4.71
Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med (2008) 4.64
Community-level comparisons between the grocery store environment and individual dietary practices. Prev Med (1991) 4.45
Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics (2001) 4.30
Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke (1991) 4.21
Bicycle helmet use by children. Evaluation of a community-wide helmet campaign. JAMA (1989) 4.21
Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med (1996) 4.11
Selection and characterization of bovine aortic endothelial cells. In Vitro (1978) 4.09
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol (1994) 4.08
Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2009) 3.91
Effect of a ban on carrying firearms on homicide rates in 2 Colombian cities. JAMA (2000) 3.91
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest (1988) 3.76
Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry (1994) 3.75
Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med (2004) 3.66
Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet (1998) 3.61
Are drugs within a class interchangeable? Lancet (1999) 3.58
Effectiveness of a violence prevention curriculum among children in elementary school. A randomized controlled trial. JAMA (1997) 3.50
Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA (1995) 3.48
JNC VI: timing is everything. Lancet (1997) 3.48
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A (1989) 3.37
Lessons from a trial of acupuncture and massage for low back pain: patient expectations and treatment effects. Spine (Phila Pa 1976) (2001) 3.36
The clinical efficacy of magnetic resonance imaging in neuroimaging. Ann Intern Med (1994) 3.33
The disease-specific benefits and risks of physical activity and exercise. Public Health Rep (1985) 3.33
Time to act on drug safety. JAMA (1998) 3.22
Association of lower continuity of care with greater risk of emergency department use and hospitalization in children. Pediatrics (2001) 3.21
Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology (2003) 3.14
Absence of association between insurance copayments and delays in seeking emergency care among patients with myocardial infarction. N Engl J Med (1997) 3.12
Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology (2001) 3.07
Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature (1984) 3.06
Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med (1994) 3.04
Incidence and outcome of injury in Ghana: a community-based survey. Bull World Health Organ (1999) 3.01
The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adults. J Am Geriatr Soc (1997) 2.98
Replication of smooth muscle cells in vascular disease. Circ Res (1986) 2.98
Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology (2002) 2.98
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood (1995) 2.96
Aspartame ingestion and headaches: a randomized crossover trial. Neurology (1994) 2.91
Cell proliferation in human coronary arteries. Proc Natl Acad Sci U S A (1990) 2.90
British guidelines on managing hypertension. Provide evidence, progress, and an occasional missed opportunity. BMJ (1999) 2.83
The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med (1984) 2.80
Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol (2009) 2.79
Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol (2000) 2.77
Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol (1997) 2.76
Neighborhood socioeconomic disadvantage and mortality after stroke. Neurology (2013) 2.74
Subclinical disease as an independent risk factor for cardiovascular disease. Circulation (1995) 2.71
Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc (1999) 2.71
Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest (1991) 2.70
Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science (1986) 2.67
Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest (1992) 2.62
Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA (1992) 2.61
Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest (1993) 2.60
Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest (1991) 2.58
Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology (2001) 2.55
Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology (1994) 2.51
White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke (2004) 2.50
Evidence for a non-linear relationship between leg strength and gait speed. Age Ageing (1996) 2.49
Endothelial regeneration. III. Time course of intimal changes after small defined injury to rat aortic endothelium. Lab Invest (1981) 2.46
Expression of the sis gene by endothelial cells in culture and in vivo. Proc Natl Acad Sci U S A (1984) 2.41
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study. J Thromb Haemost (2007) 2.40
Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res (1991) 2.39
Differences in sociodemographic, health status, and lifestyle characteristics among American Indians by telephone coverage. Prev Med (1994) 2.37
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37
Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. J Natl Cancer Inst (1995) 2.36
Elevated risk of stroke among patients with end-stage renal disease. Kidney Int (2003) 2.35
Developmentally regulated production of platelet-derived growth factor-like molecules. Nature (1984) 2.30
Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res (1985) 2.28